USD 0.04
(14.29%)
Year | Net Debt | Net Debt Growth |
---|---|---|
2023 | -105.1 Thousand USD | -188.28% |
2022 | -36.45 Thousand USD | 90.48% |
2021 | -383.14 Thousand USD | -203.53% |
2020 | 370.08 Thousand USD | -79.26% |
2019 | 1.78 Million USD | 411.0% |
2018 | 349.23 Thousand USD | -31.41% |
2017 | 509.2 Thousand USD | 117.8% |
2016 | 233.79 Thousand USD | 0.0% |
Year | Net Debt | Net Debt Growth |
---|---|---|
2024 Q1 | 14.25 Thousand USD | 113.56% |
2023 Q1 | 75.21 Thousand USD | 306.32% |
2023 Q4 | -105.1 Thousand USD | 40.87% |
2023 Q3 | -177.76 Thousand USD | -283.54% |
2023 Q2 | 96.85 Thousand USD | 28.76% |
2023 FY | -105.1 Thousand USD | -188.28% |
2022 Q3 | 91.47 Thousand USD | 263.29% |
2022 Q1 | -38.76 Thousand USD | 89.88% |
2022 FY | -36.45 Thousand USD | 90.48% |
2022 Q4 | -36.45 Thousand USD | -139.86% |
2022 Q2 | -56.01 Thousand USD | -44.49% |
2021 Q3 | -595.69 Thousand USD | -124.51% |
2021 FY | -383.14 Thousand USD | -203.53% |
2021 Q2 | 2.43 Million USD | 1.45% |
2021 Q1 | 2.39 Million USD | 10.37% |
2021 Q4 | -383.14 Thousand USD | 35.68% |
2020 Q4 | 2.17 Million USD | 0.0% |
2020 FY | 370.08 Thousand USD | -79.26% |
2019 FY | 1.78 Million USD | 411.0% |
2018 FY | 349.23 Thousand USD | -31.41% |
2017 Q4 | -4.67 USD | 0.0% |
2017 FY | 509.2 Thousand USD | 117.8% |
2016 FY | 233.79 Thousand USD | 0.0% |
Name | Net Debt | Net Debt Difference |
---|---|---|
American Medical Technologies Inc. | 479.63 Thousand USD | 121.913% |
Ansell Limited | -54.99 Million USD | 99.809% |
Ansell Limited | -55.1 Million USD | 99.809% |
BG Medicine, Inc. | - USD | Infinity% |
Biotage AB (publ) | -36.49 Million USD | 99.712% |
BioLife Sciences Inc. | - USD | Infinity% |
Psykey, Inc. | 634.59 Thousand USD | 116.562% |
ConvaTec Group Plc | 1.2 Billion USD | 100.009% |
ConvaTec Group Plc | 1.2 Billion USD | 100.009% |
Encision Inc. | 1.29 Million USD | 108.143% |
Golden Valley Development, Inc | - USD | Infinity% |
Hear AtLast Holdings, Inc. | 2.3 Million USD | 104.552% |
Innovative MedTech Inc. | 1.76 Million USD | 105.956% |
LifePoint, Inc. | -3.26 Million USD | 96.78% |
Medite Cancer Diagnostics, Inc. | 4.9 Million USD | 102.143% |
Paradigm Medical Industries, Inc. | 2.16 Million USD | 104.861% |
QuantRx Biomedical Corporation | - USD | Infinity% |
Remedent, Inc. | -43.3 Thousand USD | -142.707% |
Reflect Scientific, Inc. | -1.03 Million USD | 89.848% |
SmileDirectClub, Inc. | 778.67 Million USD | 100.013% |
Sector 10, Inc. | 163 Thousand USD | 164.48% |
Shandong Weigao Group Medical Polymer Company Limited | -417.55 Million USD | 99.975% |
SheerVision, Inc. | 57.34 Thousand USD | 283.267% |
United Health Products, Inc. | 660.56 Thousand USD | 115.911% |
Vasamed, Inc. | 22.12 Thousand USD | 575.102% |
Wearable Health Solutions, Inc. | 2.63 Million USD | 103.994% |
Yubo International Biotech Limited | 772.27 Thousand USD | 113.609% |